Literature DB >> 12725793

Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.

Helena Reijonen1, William W Kwok.   

Abstract

The highly specific interaction between major histocompatibility complex (MHC)/peptide and its cognate T-cell receptor (TCR) directs to the specificity of the T-cell response. Although the interaction affinity of individual MHC/peptide and TCR molecules is low, multimerization of the MHC/peptide complexes increases the avidity of their interaction with TCRs, and enables the complexes to be used as staining reagents for antigen-specific T cells. Different approaches are used to generate class I and class II tetramer reagents, and these reagents have been demonstrated to be useful in identifying CD8+ and CD4+ T cells, respectively. This article focuses on the uses of human lymphocyte antigen (HLA) class II tetramers in tracking antigen-specific T cells. Class II tetramers can also be used to map antigenic epitopes of known antigens through a novel peptide screening procedure known as tetramer-guided epitope mapping (TGEM). In this article, we provide a description of the methodological approach of using HLA class II tetramers in tracking and isolating T cells, and the use of class II tetramers in mapping T-cell epitopes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725793     DOI: 10.1016/s1046-2023(02)00350-x

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  23 in total

Review 1.  The Immune Tolerance Network at 10 years: tolerance research at the bedside.

Authors:  Jeffrey A Bluestone; Hugh Auchincloss; Gerald T Nepom; Daniel Rotrosen; E William St Clair; Laurence A Turka
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

2.  Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.

Authors:  Arno Hänninen; Merja Soilu-Hänninen; Christiane S Hampe; Angie Deptula; Kelly Geubtner; Jorma Ilonen; Mikael Knip; Helena Reijonen
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

3.  Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.

Authors:  G C Harcourt; T J Scriba; N Semmo; S Bounds; E Taylor; P Klenerman
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 4.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

5.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

6.  A Human IgE Antibody Binding Site on Der p 2 for the Design of a Recombinant Allergen for Immunotherapy.

Authors:  Jill Glesner; A Brenda Kapingidza; Magdalena Godzwon; Lesa R Offermann; Geoffrey A Mueller; Eugene F DeRose; Paul Wright; Crystal M Richardson; Judith A Woodfolk; Lisa D Vailes; Sabina Wünschmann; Robert E London; Martin D Chapman; Mats Ohlin; Maksymilian Chruszcz; Anna Pomés
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

7.  Production of primary human CD4⁺ T cell lines and clones.

Authors:  Jessica Matthis; Helena Reijonen
Journal:  Methods Mol Biol       Date:  2013

8.  Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.

Authors:  Rosa Faner; Eddie James; Laurie Huston; Ricardo Pujol-Borrel; William W Kwok; Manel Juan
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

9.  Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies.

Authors:  Simona Cernea; Kevan C Herold
Journal:  Clin Immunol       Date:  2010-02       Impact factor: 3.969

10.  Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.

Authors:  Kevan C Herold; Barbara Brooks-Worrell; Jerry Palmer; H Michael Dosch; Mark Peakman; Peter Gottlieb; Helena Reijonen; Sefina Arif; Lisa M Spain; Clinton Thompson; John M Lachin
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.